# Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)

> **NCT00740610** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 124 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** GS-9450
- **DRUG:** GS-9450 Placebo

## Key facts

- **NCT ID:** NCT00740610
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740610, "Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00740610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*